ICP-189

N/A

Report date: 2023/09/13 13:51:03
NME

Base Information

Drug NameICP-189
Drug Alias NameICP-189
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitorsProtein allosteric inhibitors
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnoCare Pharma Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInnoCare Pharma LtdBeijing Innocare Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A